P16 deletion and mutation analysis in human brain tumors.
about
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant gliomaCDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients.Molecular heterogeneity in medulloblastoma with implications for differing tumor biology.Classifying the medulloblastoma: insights from morphology and molecular genetics.Genetic and epigenetic alterations in primary-progressive paired oligodendroglial tumors.MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children.Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y)Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.Isolation and characterization of glioblastoma-associated homozygously deleted DNA fragments from chromosomal region 9p21 suggests involvement of multiple tumour suppressor genes.
P2860
Q28287898-9F15D65E-2889-47F2-898C-9DCF104939F6Q30353881-1ABAC345-3DD0-4948-AD76-DC8501AFAECBQ33779968-B1D11EB4-6E18-4552-9D99-233D1D150D18Q34783428-27432E68-65DF-43A9-A9A6-941505BC98BFQ34796547-CD7FCF42-B8A3-4259-9B97-F5CF6297F11FQ35867473-B8C87ECD-A47F-4841-AF70-161EBE188626Q36619285-5B4A0ABB-8193-451B-B683-938D177CF14AQ36830940-1CC372D4-C186-40AC-AF09-2719FAA56B73Q39202332-010F3CFA-FC32-45F9-8ECD-F406C82DE32EQ40290430-7A6BDEAA-CA44-4601-8ACD-A16B13E8000BQ42062520-C7FDC3D2-84A5-4E5D-9A3A-6A3DB158631DQ49150021-884557DC-017B-4BE5-BA58-DF11027E635CQ54123926-43D59F31-91F9-4EDB-86DF-C8A5C994C068Q55474087-B83B35A0-52E7-4B69-8FAA-C72D1522F0C0Q55476524-FC0AE15B-6023-478B-9E17-104D1ABA8251
P2860
P16 deletion and mutation analysis in human brain tumors.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
P16 deletion and mutation analysis in human brain tumors.
@ast
P16 deletion and mutation analysis in human brain tumors.
@en
type
label
P16 deletion and mutation analysis in human brain tumors.
@ast
P16 deletion and mutation analysis in human brain tumors.
@en
prefLabel
P16 deletion and mutation analysis in human brain tumors.
@ast
P16 deletion and mutation analysis in human brain tumors.
@en
P2093
P356
P1476
P16 deletion and mutation analysis in human brain tumors.
@en
P2093
P2888
P356
10.1023/A:1005768910871
P577
1997-01-01T00:00:00Z
P6179
1001292746